|
1
|
Kiernan J, Hu S, Grynpas MD, Davies JE and
Stanford WL: Systemic Mesenchymal Stromal Cell Transplantation
Prevents Functional Bone Loss in a Mouse Model of Age-Related
Osteoporosis. Stem Cells Transl Med. 5:683–693. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Compston JE, McClung MR and Leslie WD:
Osteoporosis. Lancet. 393:364–376. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Q, Shou P, Zheng C, Jiang M, Cao G,
Yang Q, Cao J, Xie N, Velletri T, Zhang X, et al: Fate decision of
mesenchymal stem cells: Adipocytes or osteoblasts? Cell Death
Differ. 23:1128–1139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tae JY, Lee H, Lee H, Ko Y and Park JB:
Osteogenic potential of cell spheroids composed of varying ratios
of gingiva-derived and bone marrow stem cells using concave
microwells. Exp Ther Med. 16:2287–2294. 2018.PubMed/NCBI
|
|
6
|
Almalki SG and Agrawal DK: Key
transcription factors in the differentiation of mesenchymal stem
cells. Differentiation. 92:41–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He S, Yang S, Zhang Y, Li X, Gao D, Zhong
Y, Cao L, Ma H, Liu Y, Li G, et al: LncRNA ODIR1 inhibits
osteogenic differentiation of hUC-MSCs through the
FBXO25/H2BK120ub/H3K4me3/OSX axis. Cell Death Dis. 10:9472019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin Q, Wang J, Fu Q, Gu S and Rui Y:
CircRUNX2 through has-miR-203 regulates RUNX2 to prevent
osteoporosis. J Cell Mol Med. 22:6112–6121. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li CJ, Cheng P, Liang MK, Chen YS, Lu Q,
Wang JY, Xia ZY, Zhou HD, Cao X, Xie H, et al: MicroRNA-188
regulates age-related switch between osteoblast and adipocyte
differentiation. J Clin Invest. 125:1509–1522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moerman EJ, Teng K, Lipschitz DA and
Lecka-Czernik B: Aging activates adipogenic and suppresses
osteogenic programs in mesenchymal marrow stroma/stem cells: The
role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling
pathways. Aging Cell. 3:379–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu J, Zhang W, Ran Q, Xiang Y, Zhong JF,
Li SC and Li Z: The differentiation balance of bone marrow
mesenchymal stem cells is crucial to hematopoiesis. Stem Cells Int.
2018:15401482018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu B and Wang CY: Osteoporosis: The result
of an ‘aged’ bone microenvironment. Trends Mol Med. 22:641–644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khosla S and Hofbauer LC: Osteoporosis
treatment: Recent developments and ongoing challenges. Lancet
Diabetes Endocrinol. 5:898–907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheung CL, Xiao SM and Kung AW: Genetic
epidemiology of age-related osteoporosis and its clinical
applications. Nat Rev Rheumatol. 6:507–517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carey JJ, Lewiecki EM, Blank RD, Shuhart
CR and Buehring B: Treatment of low bone density or osteoporosis to
prevent fractures in men and women. Ann Intern Med. 167:9012017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lorentzon M and Cummings SR: Osteoporosis:
The evolution of a diagnosis. J Intern Med. 277:650–661. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sànchez-Riera L, Carnahan E, Vos T,
Veerman L, Norman R, Lim SS, Hoy D, Smith E, Wilson N, Nolla JM, et
al: The global burden attributable to low bone mineral density. Ann
Rheum Dis. 73:1635–1645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turpeinen H, Ortutay Z and Pesu M:
Genetics of the first seven proprotein convertase enzymes in health
and disease. Curr Genomics. 14:453–467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osathanon T, Manokawinchoke J, Sa-Ard-Iam
N, Mahanonda R, Pavasant P and Suwanwela J: Jagged1 promotes
mineralization in human bone-derived cells. Arch Oral Biol.
99:134–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McPherron AC, Lawler AM and Lee SJ:
Regulation of anterior/posterior patterning of the axial skeleton
by growth/differentiation factor 11. Nat Genet. 22:260–264. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu H, Sun Q, Wan C, Li L, Zhang L and
Chen Z: MicroRNA-338-3p regulates osteogenic differentiation of
mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2.
J Cell Physiol. 229:1494–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang XH, Geng GL, Su B, Liang CP, Wang F
and Bao JC: MicroRNA-338-3p inhibits glucocorticoid-induced
osteoclast formation through RANKL targeting. Genet Mol Res.
15:gmr.15037674. 2016.
|
|
23
|
Niu D, Gong Z, Sun X, Yuan J, Zheng T,
Wang X, Fan X, Mao Y, Liu X, Tang B, et al: miR-338-3p regulates
osteoclastogenesis via targeting IKKβ gene. In Vitro Cell Dev Biol
Anim. 55:243–251. 2019. View Article : Google Scholar
|
|
24
|
Benisch P, Schilling T, Klein-Hitpass L,
Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S,
Schinke T, et al: The transcriptional profile of mesenchymal stem
cell populations in primary osteoporosis is distinct and shows
overexpression of osteogenic inhibitors. PLoS One. 7:e451422012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F, et al: CircHIPK3 sponges miR-558
to suppress heparanase expression in bladder cancer cells. EMBO
Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szumska D, Pieles G, Essalmani R, Bilski
M, Mesnard D, Kaur K, Franklyn A, El Omari K, Jefferis J, Bentham
J, et al: VACTERL/caudal regression/Currarino syndrome-like
malformations in mice with mutation in the proprotein convertase
Pcsk5. Genes Dev. 22:1465–1477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hoac B, Susan-Resiga D, Essalmani R,
Marcinkiweicz E, Seidah NG and McKee MD: Osteopontin as a novel
substrate for the proprotein convertase 5/6 (PCSK5) in bone. Bone.
107:45–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marie PJ: Targeting integrins to promote
bone formation and repair. Nat Rev Endocrinol. 9:288–295. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eastell R, O'Neill TW, Hofbauer LC,
Langdahl B, Reid IR, Gold DT and Cummings SR: Postmenopausal
osteoporosis. Nat Rev Dis Primers. 2:160692016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Long H, Sun B, Cheng L, Zhao S, Zhu Y,
Zhao R and Zhu J: miR-139-5p represses BMSC osteogenesis via
targeting Wnt/β-catenin signaling pathway. DNA Cell Biol.
36:715–724. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang S, Liu Y, Zheng Z, Zeng X, Liu D,
Wang C and Ting K: MicroRNA-223 suppresses osteoblast
differentiation by inhibiting DHRS3. Cell Physiol Biochem.
47:667–679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu L, Liu H and Lei W: MiR-596 inhibits
osteoblastic differentiation and cell proliferation by targeting
Smad3 in steroid-induced osteonecrosis of femoral head. J Orthop
Surg Res. 15:1732020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou S, Qian B, Wang L, Zhang C, Hogan MV
and Li H: Altered bone-regulating myokine expression in skeletal
muscle Of Duchenne muscular dystrophy mouse models. Muscle Nerve.
58:573–582. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bartold M, Gronthos S, Haynes D and
Ivanovski S: Mesenchymal stem cells and biologic factors leading to
bone formation. J Clin Periodontol. 46 (Suppl 21):12–32. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alcorta-Sevillano N, Macías I, Rodríguez
CI and Infante A: Crucial role of Lamin A/C in the migration and
differentiation of MSCs in bone. Cells. 9:E13302020. View Article : Google Scholar : PubMed/NCBI
|
